Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$1.43
NASDAQLPCN
Open
$1.36
Change
$0.06 (4.73%)
Day's Range
$1.35 - $1.45
52-Week Range
$0.31 - $3.25
Volume
892.3K
Market Cap
$94.2M